Table 2.
Expression of HIF-1α and HIF-2α within Tumor Cell Nuclei
| Tumor type | No. of cases | HIF-1α and HIF-2α positive | HIF-1α-positive only | HIF-2α-positive only | HIF-1α and HIF-2α negative |
|---|---|---|---|---|---|
| Bladder adenocarcinoma | 5 | 2 | 0 | 0 | 3 |
| Glioblastoma multiforme | 5 | 2 | 0 | 0 | 3 |
| Breast adenocarcinoma | 12 | 10 | 0 | 1 | 1 |
| Colon adenocarcinoma | 5 | 4 | 0 | 0 | 1 |
| Hepatocellular carcinoma | 5 | 2 | 0 | 0 | 3 |
| Hypernephroma | 5 | 2 | 2 | 0 | 1 |
| Lung tumors (squamous cell, adenocarcinoma) | 5 | 0 | 0 | 0 | 5 |
| Ovarian adenocarcinoma | 5 | 5 | 0 | 0 | 0 |
| Pancreatic adenocarcinoma | 3 | 2 | 0 | 1 | 0 |
| Prostatic adenocarcinoma | 5 | 2 | 0 | 1 | 2 |
| Buffy coat chronic myeloid leukemia | 2 | 0 | 0 | 0 | 2 |
| Totals | 57 | 31 | 2 | 3 | 21 |
In addition, HIF-2α expression was detected within subsets of tumor-associated macrophages in all cases.